Alvotech (ALVO) Long-Term Investments (2020 - 2024)
Alvotech's (ALVO) quarterly Long-Term Investments came in at $18.5 million in Q1 2024, down 61.14% YoY from $47.6 million in Q2 2023, and little changed on a QoQ basis from $18.5 million in Q4 2023.
Alvotech (ALVO) Long-Term Investments (2020 - 2024) Analysis & Trends
Alvotech (ALVO) has 5 years of Long-Term Investments data on file, last reported at $18.5 million in Q1 2024.
- Quarterly Long-Term Investments fell 61.14% year-over-year to $18.5 million in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $18.5 million (down 61.14% YoY) and the FY2023 annual result came in at $18.5 million, down 61.92% from the prior year.
- Long-Term Investments held at $18.5 million in Q1 2024, from $18.5 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $56.7 million in Q4 2020 to a low of $18.5 million in Q4 2023.
- A 5-year average of $42.5 million and a median of $48.1 million in 2022 frame the typical range for Long-Term Investments.
- Annual changes were most pronounced in 2021 — Long-Term Investments fell 2.42% — and 2023, when it tumbled 61.92%.
- Tracing ALVO's Long-Term Investments over 5 years: stood at $56.7 million in 2020, then dropped by 2.42% to $55.3 million in 2021, then declined by 12.18% to $48.6 million in 2022, then tumbled by 61.92% to $18.5 million in 2023, then changed by 0.0% to $18.5 million in 2024.
- The last three Long-Term Investments figures came in at $18.5 million (Q1 2024), $18.5 million (Q4 2023), and $43.6 million (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 92.58 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 63.23 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 1.14 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 60.00 Mn |
| 10 | Alvotech | 1.26 Bn | 1.26 Bn | 5.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 18.49 Mn |
| Dec 31, 2023 | 18.49 Mn |
| Jun 30, 2023 | 43.61 Mn |
| Mar 31, 2023 | 47.59 Mn |
| Dec 31, 2022 | 48.57 Mn |
| Jun 30, 2022 | 51.33 Mn |
| Dec 31, 2021 | 55.31 Mn |
| Dec 31, 2020 | 56.68 Mn |